TGFB1 and neoplasm: Specifically, EVs released by glioblastoma tumor cells can carry VEGF, transforming growth factor-β (TGF-β), chemokines, and proteolytic enzymes as cargo, all of which are pro-angiogenic factors that play an active role in altering tumor vasculature [54,55].